AwardedCzechiaGoodsCZK 8,800,000
Monoklonální protilátka - Dupilumab I.
- Published
- Published 9 October 2025
- Deadline
- Closed 11 November 2025
Overview
Předmětem veřejné zakázky jsou pravidelné dodávky léčivých přípravků pro parenterální podání s obsahem monoklonální protilátky třídy IgG4 dupilumab (ATC skupina D11AH05) pro léčbu pacientů ve schválených indikacích dle SPC platného ke dni podání nabídek.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 8,800,000
- Procedure
- Open
- SME suitable
- Yes
- Published
- 9 October 2025
- Deadline
- Closed
Immunoglobulins
Award outcome
- Awarded value
- CZK 4,725,066
- Award date
- 19 November 2025
- Contract period
- 7 January 2026 → 7 January 2030
- Sanofi s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
8 January 2026
Contract Notice
9 October 2025
Contracting authority
Institut klinické a experimentální medicíny
Procuring entityPraha, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.